Fresenius medical care simplifies corporate structure by converting into a german stock corporation

Extraordinary general meeting approves conversion of fresenius medical care's legal form several advantages including faster and more agile decision-making michael sen elected as chair of new supervisory board conversion expected to be completed by the end of 2023 waltham, mass., july 14, 2023 /prnewswire/ -- fresenius medical care, the world's leading provider of products and services for individuals with renal diseases, held an extraordinary general meeting (egm) today.
FMS Ratings Summary
FMS Quant Ranking